INDUSTRY SYMPOSIA
AUDITORIUM / LEVEL -1
THURSDAY JANUARY 23
16.00
Symposium 
Clinical considerations and real-world results with the Cook Zenith platform
-The French multicenter post-market thoracic study, Ludovic Berger
-AAA European guidelines and the impact of indications on durable outcomes. Long-term experience with the Cook AAA devices, Stephan Haulon
17.40
Symposium
Moderator: Jean Pierre BECQUEMIN
Aortic arch FET treatment using Thoraflex™ hybrid
The surgical hybrid stent graft
-Epiflex French registry: rational and sequential analysis of early outcomes: T. Caus
-FET, multidisciplinary approach, Pre, Per and Post procedure: X. Chaufour
-FET, HEGP Paris results: C. H. Gautier
FRIDAY JANUARY 24
10.50
Symposium 
Moderators: J. Busquet & S. Haulon
-Endurant long term performance: results from trials and technical aspects, J. P. Becquemin
-How to maintain high sac regression rates in hostile necks: the role of endoanchors, A. Millon
-Type II EL: how to minimize a contributing factor to failure to regress, D. Fabre
SATURDAY JANUARY 25
09.50
Symposium 
GORE® VIABAHN® endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Modérateur : Yann Goueffic
-Femoropopliteal bypasses with heparin-bonded PTFE are a durable treatment for long SFA-popliteal occlusions: when they are the best treatment and why, Nellie Della Schiava
-How to achieve good results with GORE® VIABAHN® endoprosthesis for treating complex femoropopliteal occlusive disease – clinical cases, Bertrand Saint Lebes
-Discussion animated by Yann Goueffic
11.30
Symposium 
Published Lutonix® safety data and the value of the Ultrascore™ device:
Moderator: Eric Ducasse
-Lutonix® clinical program overview and published independent safety analysis results: Y. Goueffic
-How low pressure inflation with scoring technologies better preserves the vessel and increases revascularization success: R. Langhoff
INDUSTRY SYMPOSIA
ROOM B / LEVEL 0
FRIDAY JANUARY 24
Simultaneous translation:
Headphones will be available on request
(only if a valid ID is presented) when entering the room.